⌘K

Login Start Free

Home/Filings/4/0001213900-25-003838

4//SEC Filing

Knie Robb 4

Accession 0001213900-25-003838

CIK 0001711786other

View on SEC.gov Company Profile

Filed

Jan 14, 7:00 PM ET

Accepted

Jan 15, 4:15 PM ET

Size

7.8 KB

Accession

0001213900-25-003838

Insider Transaction Report

Form 4

Period: 2025-01-14

Hoth Therapeutics, Inc.HOTH

DirectorCEO and President

Transactions

Award
Options
2025-01-14+93,000→ 93,000 total
Exercise: $1.55From: 2025-01-14Exp: 2035-01-14→ Common Stock (93,000 underlying)
Award
Options
2025-01-14+7,000→ 7,000 total
Exercise: $1.55From: 2025-01-14Exp: 2035-01-14→ Common Stock (7,000 underlying)

Footnotes (2)

[F1]The options were issued pursuant to the Issuer's 2018 Equity Incentive Plan, as amended, and vested in full upon grant.
[F2]The options were issued pursuant to the Issuer's Amended and Restated 2022 Equity Incentive Plan, as amended, and vested in full upon grant.

Documents

1 file

4
ownership.xmlPrimary

Issuer

Hoth Therapeutics, Inc.

CIK 0001711786

Entity typeother

Related Parties

1

filerCIK 0001609695

Filing Metadata

Form type: 4
Filed: Jan 14, 7:00 PM ET
Accepted: Jan 15, 4:15 PM ET
Size: 7.8 KB

View on SEC.gov